EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effects of Topical Antifibrinolytics in Endoscopic Sinus Surgery: A Pilot Randomized Controlled Trial

Theodore Athanasiadis, Achim G Beule, Peter J Wormald

American Journal of Rhinology · 2007-11 · 21 (6) · 737-742

DOI: 10.2500/ajr.2007.21.3097 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Rhinology, online erschienen am 01.11.2007. Verfasst von Theodore Athanasiadis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, The Queen Elizabeth Hospital, University of Adelaide, Australia. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bleeding in endoscopic sinus surgery (ESS) may increase the risk of intraoperative complications and is associated with poorer outcomes Antifibrinolytic agents have been shown to reduce bleeding if administered systemically. The aim of this study was to determine the effect of topical epsilon-aminocaproic acid (EACA) and tranexamic acid (TA) on bleeding in the surgical field during ESS.

Methods

A prospective blind randomized controlled trial was performed. Thirty patients undergoing ESS were randomized to receive either 2.5 g of EACA, 100 mg of TA, or 1 g of TA while the contralateral side received saline. The solution was applied as a spray at the conclusion of operating on each side. Bleeding was documented using standardized videoendoscopy and grading scales.

Results

EACA did not show a significant effect on intraoperative bleeding. TA at 100 mg showed a clinically significant improvement in the surgical field at 2, 4, and 6 minutes after application. The mean for 2 minutes was TA, 1.6 ± 1.08, and control, 2.2 ± 1.3; at 4 minutes was TA, 1.25 ± 1.2, and control, 1.7 ± 1.2,; and at 6 minutes was TA, 0.75 ± 1.2, and control, 1.3 ± 1.4 (p < 0.05). TA at 1 g also approached significance at all time points. Combined results from the two TA groups showed a significant improvement in the surgical field at 2, 4, 6, and 8 minutes after application. TA was regarded by the blinded surgeon as more effective than saline in 80% of cases. No adverse effects were encountered after topical application of either drug.

Conclusion

Topical application of TA is effective in achieving hemostasis and improving the surgical field. In contrast to EACA, TA is a valuable tool in ESS that merits additional evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAminocaproic AcidAntifibrinolytic AgentsBlood Loss, SurgicalDouble-Blind MethodEndoscopyFemaleHemostasis, SurgicalHumansMaleMiddle AgedNimodipineParanasal Sinus DiseasesPilot ProjectsTranexamic Acid

Substanzen

Antifibrinolytic AgentsNimodipineTranexamic AcidAminocaproic Acid

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, The Queen Elizabeth Hospital, University of Adelaide, Australia.

Zitieren

APA

Athanasiadis, T., Beule, A. G., & Wormald, P. J. (2007). Effects of Topical Antifibrinolytics in Endoscopic Sinus Surgery: A Pilot Randomized Controlled Trial. American Journal of Rhinology, 21(6), 737-742. https://doi.org/10.2500/ajr.2007.21.3097

Vancouver

Athanasiadis T, Beule AG, Wormald PJ. Effects of Topical Antifibrinolytics in Endoscopic Sinus Surgery: A Pilot Randomized Controlled Trial. American Journal of Rhinology. 2007;21(6):737-742. doi:10.2500/ajr.2007.21.3097

BibTeX
@article{Athanasiadis2007,
  author = {Athanasiadis, Theodore and Beule, Achim G and Wormald, Peter J},
  title = {Effects of Topical Antifibrinolytics in Endoscopic Sinus Surgery: A Pilot Randomized Controlled Trial},
  journal = {American Journal of Rhinology},
  year = {2007},
  volume = {21},
  number = {6},
  pages = {737--742},
  doi = {10.2500/ajr.2007.21.3097}
}
Kostenlos starten →